Press Releases
Trophos completes patient enrolment in pivotal efficacy study of olesoxime in Spinal Muscular Atrophy
Marseille France, September 8, 2011 - Trophos SA, a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announced today the completion of patient enrolment in the...
Press Releases
Over 65% of Physicians Have Used Social Media to Support their Professional Practice
Physicians are highly engaged with social media for both personal and professional use, according to a 4,033-clinician study authored and conducted by QuantiaMD, the largest mobile and online physician community, and Care Continuum Alliance, an international association for...
Press Releases
BARDA Partners to Develop New Class of Antibiotic U.S. Department of Health and Human Services
The federal government today issued a contract for advanced research and development of a dual-purpose broad spectrum antibiotic with potential to treat illnesses caused by bioterrorism threats such as plague and tularemia, as well as more certain life-threatening...
Press Releases
Hybrigenics gets approval and funding for a Phase II clinical trial of inecalcitol in psoriasis
Hybrigenics, a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus on research and development of new treatments of proliferative diseases, announces today that AFSSAPS, the French drug agency, has granted authorization for a Phase II clinical...
Press Releases
Synta to Present at the Rodman & Renshaw Annual Global Investment Conference Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) today announced that the Company will be presenting at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, September 13 at 11:15 a.m. (ET) in New York. About Synta...
Press Releases
Launch of Cytocell Aquarius® FISH probe for Leukemia Patient Prognosis Cytocell Ltd
Cytocell announced today the launch of its latest FISH probe to aid in determining the prognosis of patients with chronic lymphocytic leukemia (CLL), a cancer of the lymphocytes. Cytocell’s Aquarius® P53/ATM Probe Combination detects cytogenetic abnormalities in bone marrow...
Press Releases
Telemedicine Technology Links Rural Arizona to Concussion Care at Mayo Clinic
A pilot program at Mayo Clinic using telemedicine technology is showing promise for patients with concussions in rural Arizona. Doctors at Mayo Clinic in Phoenix recently conducted a live audio-video evaluation of a 15-year-old soccer player in Show...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read